The aim of this research was to determine the potential probiotic activity of Lactobacillus acidophilus ATCC 4356 against several human Campylobacter jejuni isolates. The ability to inhibit the pathogen's growth was evaluated by co-culture experiments as well as by antimicrobial assays with cell-free culture supernatant (CFCS), while interference with adhesion/invasion to intestinal Caco-2 cells was studied by exclusion, competition, and displacement tests. In the co-culture experiments L. acidophilus ATCC 4356 strain reduced the growth of C. jejuni with variable percentages of inhibition related to the contact time. The CFCS showed inhibitory activity against C. jejuni strains, stability to low pH, and thermal treatment and sensitivity to proteinase K and trypsin. L. acidophilus ATCC 4356 was able to reduce the adhesion and invasion to Caco-2 cells by most of the human C. jejuni strains. Displacement and exclusion mechanisms seem to be the preferred modalities, which caused a significant reduction of adhesion/invasion of pathogens to intestinal cells. The observed inhibitory properties of L. acidophilus ATCC 4356 on growth ability and on cells adhesion/invasion of C. jejuni may offer potential use of this strain for the management of Campylobacter infections.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00284-012-0080-0 | DOI Listing |
Prep Biochem Biotechnol
February 2025
Microbial Institute for Fermentation Industry (MIFI), Sunchang, Korea.
In this study, the enhancement of the phytoremediation and biosorption properties of the cationic dye methylene blue using ATCC 26774 were investigated. Inoculation with ATCC 26774 increased the length of roots by 82.3% and stems by 37.
View Article and Find Full Text PDFBiology (Basel)
January 2025
Biology Department, Faculty of Science, Al-Baha University, Al-Baha 65779, Saudi Arabia.
Gut microbiota plays a pivotal role in various health challenges, particularly in mitigating diabetes-induced renal damage. Numerous studies have highlighted that modifying gut microbiota is a promising therapeutic strategy for preserving kidney function and mitigating diabetes-related complications. This study aimed to evaluate the protective effects of ATCC 4356 supplementations on kidney health in a rat model of diabetes-induced renal damage.
View Article and Find Full Text PDFJ Microbiol Biotechnol
November 2024
Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal- 576104, Karnataka, India.
Hypercholesterolemia is a risk factor of coronary heart disease and cholesterol-lowering probiotics are seen as alternative to drugs for the management of this condition. In the present study, we evaluated the cholesterol-lowering activity of KS6I1 in high-cholesterol diet-induced hypercholesterolemic mice. The mice were fed with high-cholesterol diet (HCD) and were divided into three groups: HCD group, KS6I1 group (fed with HCD + 200 μl of 10 CFU/ml KS6I1), and L.
View Article and Find Full Text PDFMicroorganisms
November 2024
Molecular Food Microbiology Laboratory, Department of Food Science, Purdue University, West Lafayette, IN 47907, USA.
Gut dysbiosis and an inflamed bowel are growing concerns in mammals, including dogs. Probiotic supplements have been used to restore the natural microbial community and improve gastrointestinal health. Biofilm formation, antimicrobial activities, and immunological responses of probiotics are crucial to improving gut health.
View Article and Find Full Text PDFAm J Orthod Dentofacial Orthop
January 2025
Discipline of Orthodontics and Paediatric Dentistry, School of Dentistry, The University of Sydney, Sydney, Australia. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!